Compare USPH & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | USPH | AORT |
|---|---|---|
| Founded | 1990 | 1984 |
| Country | United States | United States |
| Employees | 5500 | 1800 |
| Industry | Medical/Nursing Services | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 1996 | 1996 |
| Metric | USPH | AORT |
|---|---|---|
| Price | $63.07 | $23.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $101.67 | $49.40 |
| AVG Volume (30 Days) | 195.2K | ★ 640.2K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.57% | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | N/A | ★ 0.03 |
| Revenue | ★ $780,990,000.00 | $298,836,000.00 |
| Revenue This Year | $10.62 | $14.20 |
| Revenue Next Year | $6.30 | $11.20 |
| P/E Ratio | ★ N/A | $765.67 |
| Revenue Growth | 16.33 | ★ 18.01 |
| 52 Week Low | $58.19 | $19.16 |
| 52 Week High | $93.50 | $48.25 |
| Indicator | USPH | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 37.48 | 23.06 |
| Support Level | $58.19 | $19.16 |
| Resistance Level | $86.52 | $38.43 |
| Average True Range (ATR) | 3.77 | 1.97 |
| MACD | -0.58 | -1.40 |
| Stochastic Oscillator | 27.94 | 21.21 |
US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.